The incidence of fetal loss in SLE will rise by the existence of renal or neurological involvement, and the presence of certain antibodies such as anti-Ro/SSA anti-La/SSB, anti-thyroglobulin and especially antiphospholipid antibodies (aPLs) (24). This evidence concerns the gene CALR and systemic lupus erythematosus.